Selvedge Venture
Venture capitalLondon · Pre-Seed–Series A · 3 people tracked
Find your way into Selvedge Venture
1,052 people in our graph share verified history with the Selvedge Venture team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Selvedge Venture pursues impact investing aimed at alleviating the healthcare burden caused by age-related medical conditions, which it notes account for over 60% of loss of human life. The firm concentrates on three condition areas: metabolic syndrome (including cardiovascular disease, diabetes, fatty liver disease and obesity), cancer and neurodegenerative diseases, each carrying a large burden of excess deaths and healthcare spend. Its core expertise sits at the intersection of biotechnology and digital technologies, leveraging biotech, machine learning tools and integrated data assets to shape healthcare and life sciences. It backs pre-seed, seed and Series A ready companies.
Source: firm website, verified Sep 26, 2026.
What founders say
No founder feedback on Selvedge Venture yet.
Team · 3 people
from the firm's websiteFounder mafia
3 people who came through Selvedge Venture went on to found or lead other companies.
What they invest in
from 15 of 25 portfolio companiesBiotech ×12AI & Machine Learning ×7Healthtech ×7Deep Tech ×4Digital Health ×4EdTech ×4Medical Devices ×4Impact & Social Good ×3
HQs:United Kingdom×6United States×5Denmark×1
Who they back
founder profiles across 6 portfolio companiesAccelerator rootsportfolio companies that came through a program
Investments · 25 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12022 · 12021 · 14 dated
Alcolase is a biotech company developing science-based solutions for people with alcohol intolerance, a genetic condition affecting hundreds of millions of people, particularly in East Asia.
BiotechConsumerWellness & FitnessCopenhagen, DK
Mikkel Precht(Founder)in
Co-investorsAda VenturesAntlerAntler AustraliaDelphinus Venture CapitalElmehøj Ventures
Selvedge Venture is a venture capital firm that invests in Pre-Seed, Seed and Series A startups working to address age-related medical conditions, focusing on metabolic syndrome, cancer and neurodegenerative diseases.
AI & Machine LearningBiotechHealthtech
BIOS develops neural digital therapy technology to deliver treatments for neurological conditions.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Oliver Armitage(Founder)inEmil Hewage(Founder/Director)in
Co-investorsFifty YearsFOUNDER.orgHeuristic Capital PartnersKern Venture GroupThe Venture CollectiveY Combinator+6 more
MIT is an educational and research institution in Cambridge, Massachusetts, pursuing teaching, research, and innovation across science, engineering, and other fields.
BiotechEdTechCambridge, US
Co-investorsBeyond Earth VenturesFlagship PioneeringFoundersX VenturesJIMCOLair East LabsMassChallenge Mexico
Carbometrics is developing i-CAM, a continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits used in medical procedures.
HardwareHealthtechMedical Devices
Co-investorsAda VenturesScience Creates Ventures
Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in
Co-investorsEntrepreneur FirstJude GomilaUnruly CapitalCambridge Angels groupNadav RosenbergR42 Group
Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.
BiotechDeep TechHardwareCambridge, US
Cullen Buie(Founder; Board Observer)inPaulo Garcia(Founder)inMichael Chiu(Chief Executive Officer)in
BoardPaxton Major(Director)inAnn DeWitt(Director)inPaul Wotton(Director)
Co-investorsBantam GroupHorizons VenturesMassVenturesTBD AngelsTelegraph Hill PartnersThe Engine Ventures+2 more
DARA's Result Interpretation Module provides a digitalized workflow that replaces manual document handling processes for specialists, eliminating printing, scanning, email distribution, and courier services in healthcare result management.
AI & Machine LearningBiotechDigital HealthHealthtech
Dr Andrew Wu(Co-Founder and CEO)Arsen Batagov(Co-Founder)in
Co-investorsElev8.vc
Multiomic Health applies systems biology and data science to omics datasets for drug discovery and development in cardiometabolic and related diseases, working through R&D partnerships with biopharma organizations.
AI & Machine LearningBiotechDigital HealthLondon, GB
Robert Thong(Co-founder & CEO)inAlasdair Thong(Co-founder & Non-Executive Director)inCelia Schell(Chief Clinical Officer & Chief Operating Officer)inMichael Sierra(Chief Scientific Officer)inAriella Cohain(Chief Technology Officer)inEsra Berkol(Chief of Staff)in
Co-investorsFifty YearsHoxton VenturesMMC VenturesVerve VenturesAda Ventures
Liver transplant and drug testing
Co-investorsah! VenturesKhosla VenturesLifeforce CapitalNorrsken VC
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(Founder/CSO)inJack O'Meara(Founding CEO)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+15 more
Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.
BiotechDigital HealthHealthtechMedical DevicesOxford, GB
Co-investorsOxford Investment Opportunity Network (OION)Ada Ventures
The Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications.
BiotechClimate TechEdTechEnergyImpact & Social GoodMedia & EntertainmentLondon, GB
Thomas Graham(First President)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AvroBiosKytoMesBioOxford MedicalPharmaPharma CCXSanomeYuri
Portfolio news
latest coverage across their companiesAlcolase · eu-startups.com · May 18, 2026
Kytopen · finsmes.com · Apr 7, 2026
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2021
Director · British · since 2021
Robert Thong — 25–50% of shares, 25–50% of voting rights
Alasdair Robert Thong — 25–50% of shares, 25–50% of voting rights
Selvedge Innovation Llp — 75–100% of shares, 75–100% of voting rights
Frequently asked questions
- How many investments has Selvedge Venture made?
- Selvedge Venture has 25 tracked investments, including 1 dated in the last 24 months.
- What stage does Selvedge Venture invest at?
- Selvedge Venture invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Selvedge Venture focus on?
- Selvedge Venture focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Fintech, Healthtech, Impact & Social Good, Longevity, Medical Devices, Space Tech.
- Where is Selvedge Venture located?
- Selvedge Venture is headquartered in London, GB.
- Who does Selvedge Venture co-invest with?
- Selvedge Venture most often shares deals with Entrepreneur First, Hoxton Ventures, Flagship Pioneering, among 28 tracked co-investors.
Media · Podcasts & interviews
featuring the teamProject Astra | Exploring the Capabilities of a Universal AI Assistant
Google · Alasdair Thong
Images
Co-investors · 2
Ada Ventures is a venture capital firm that backs early-stage founders, offering support such as back-up childcare, founder welfare resources, a growth specialist for sales and go-to-market, and a dedicated talent partner to help build teams.
Cambridge Angels is a UK business angel network that has been providing capital and operational support to entrepreneurs since 2001, backing more than 150 companies.
Firms observed investing alongside Selvedge Venture, from public investor directories. Shared companies are the overlap with Selvedge Venture's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Rising Tide is a venture capital firm investing across sectors including healthcare, life sciences, AI infrastructure, space and communications, fintech, and crypto.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.








.jpeg)



































.jpeg)













